Bio-Reference (BRLI) Authorizes 1M Common Buyback
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Join SI Premium – FREE
Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that its board of directors has approved a Stock Repurchase Program authorizing the repurchase of up to 1,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices through October 31, 2012.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Service Corporation International boosts share buyback plan by $472 million
- SES launches share buyback of up to 2.97 million FDRs for EUR 31.2 million
- Highland fund launches $100 million share buyback program
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
